Role of acid suppressants in prophylaxis of NSAID damage

Best Practice and Research: Clinical Gastroenterology

Volumn 15, Issue 3, 2001, Pages 433-445

  Chan, Francis K L ^a   Sung, Joseph J Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Acid suppression; Helicobacter pylori; Misoprostol; Non steroidal anti inflammatory drugs; Proton pump inhibitors; Ulcer

Indexed keywords

CIMETIDINE; CYCLOOXYGENASE 2 INHIBITOR; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PLACEBO; PROSTAGLANDIN DERIVATIVE; PROTON PUMP INHIBITOR; RANITIDINE; STOMACH SECRETION INHIBITOR;

ARTICLE; CLINICAL STUDY; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; EXPERIMENTAL MODEL; GASTRODUODENAL ULCER; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HEMOSTASIS; HUMAN; PATHOGENESIS; RANDOMIZED CONTROLLED TRIAL; STOMACH ACID; STOMACH MUCOSA INJURY; STOMACH ULCER; ULCER HEALING; UPPER GASTROINTESTINAL TRACT;

EID: 0034949256     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.2001.0192     Document Type: Article

References (46)

1. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years
2. Parenteral aspirin and sodium salicylate are equally injurious to the rat gastric mucosa
3. Indomethacin damage to rat gastric mucosa is markedly dependent on luminal pH
4. The mucoid cap over superficial gastric damage in the rat. A high-pH microenvironment dissipated by nonsteroidal antiinflammatory drugs and endothelin
5. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor to prolonged gastroduodenal mucosal hemorrhage
6. Continuous intravenous infusion of famotidine for haemorrhage from peptic ulcer
7. Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: A prospective randomised controlled study
8. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours
9. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers
10. Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing
11. Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: Interaction with indomethacin
12. Indomethacin impairs quality of experimental gastric ulcer healing: A quality histologic and ultrastructural analysis
13. Prostaglandins mediate inhibition of gastric acid secretion by somatostatin in the rat
14. Effect of indomethacin and aspirin on gastric blood flow and acid secretion
15. Aspirin-induced changes in gastric function: Role of endogenous prostaglandins and mucosal damage
16. The influence of cimetidine on peptic ulcer in patients with arthritis taking anti-inflammatory drugs
17. Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers
18. Resistance to medical therapy of gastric ulcers in rheumatic disease patients taking aspirin. A double-blind study with cimetidine and follow-up
19. 2-receptor antagonists
20. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer
21. Omeprazole compared with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs
22. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs
23. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: Results of a double-blind, randomized, multicenter study
24. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: Controlled trial of ranitidine
25. Famotidine for the prevention of gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs
26. Nizatidine prevents peptic ulceration in high-risk patients taking nonsteroidal anti-inflammatory drugs
27. Effect of ranitidine on gastroduodenal mucosal damage in patients on long-term non-steroidal anti-inflammatory drugs
28. Nizatidine in therapy and prevention of non-steroidal anti-inflammatory drug-induced gastroduodenal ulcer in rheumatic patients
29. Prevention of NSAID-induced gastroduodenal ulcers (Cochrane Review)
30. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: A prospective, double-blind, multicenter study
31. Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration
32. High-dose ranitidine for the prevention of recurrent peptic ulcer disease in rheumatoid arthritis patients taking NSAIDs
33. Famotidine to prevent peptic ulcer caused by NSAIDs
34. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy
35. Primary gastroduodenal prophylaxis with omeprazole for nonsteroidal anti-inflammatory drug users
36. Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: A comparison of three regimens
37. Randomised trial of low-dose misoprostol and naproxen versus nabumetone to prevent recurrent upper gastrointestinal haemorrhage in high-risk users of non-steroidal anti-inflammatory drugs
38. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer
39. Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole
40. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study
41. Secondary prevention of upper gastrointestinal bleeding associated with maintenance acid-suppressing treatment in patients with peptic ulcer bleed
42. Nitrovasodilators, low-dose aspirin, other nonsteroidal anti-inflammatory drugs, and the risk of upper gastrointestinal bleeding
43. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen
44. A randomized trial comparing the effect of Rofecoxib, a COX-2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis
45. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis
46. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs